Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/25/1992 | CN1059758A Non-a, non-b hepatitis virus particles |
03/25/1992 | CA2052022A1 Peptides having thrombospondin-like activity and their therapeutic use |
03/25/1992 | CA2051749A1 Cell adhesion molecule |
03/24/1992 | US5099004 Antibodies such as monoclonal antibodies |
03/24/1992 | US5099003 Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii |
03/24/1992 | US5099002 Sequential improved method for treatment of human blood-clotting factor products |
03/24/1992 | US5099001 Process for the production of thyroglobulin |
03/24/1992 | US5099000 Fluorescent compounds for immunoassay as tracers |
03/24/1992 | US5098998 Protection against Vibrio |
03/24/1992 | US5098997 Vaccines for Haemophilus influenzae |
03/24/1992 | US5098995 GRF Analogs VIIA |
03/24/1992 | US5098924 Hypotensive agents and angiotensin II inhibitors |
03/24/1992 | US5098890 Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
03/24/1992 | US5098887 Angiotensin converting enzyme inhibitor |
03/24/1992 | US5098833 DNA sequence encoding a functional domain of a lymphocyte homing receptor |
03/24/1992 | US5098829 Immunoadsorbents |
03/24/1992 | US5098828 Immunoassay and testing |
03/24/1992 | US5098826 Binding and detection of antigens |
03/24/1992 | US5098722 Method of manufacturing iron-fortified beverage |
03/24/1992 | US5098705 Bioinsecticides |
03/24/1992 | US5098704 Hepatitis surface antigen particle vaccine |
03/24/1992 | US5098703 Interferon-alpha 76 |
03/24/1992 | CA1298034C Amino acid derivatives |
03/24/1992 | CA1298032C Method of preparing alpha-1-proteinase inhibitor |
03/24/1992 | CA1297825C Antibiotics called "chloropolysporins b and c" a process for their preparation, and their therapeutic and veterinary use |
03/24/1992 | CA1297819C Hybridoma tumor cell lines and their monoclonal antibodies to theumatin |
03/24/1992 | CA1297816C Platelet function inhibiting monoclonal antibody fragment |
03/24/1992 | CA1297815C Fibrinogen blocking monoclonal antibody |
03/24/1992 | CA1297814C Process for production of insulin-like growth factor i and plasmid for production thereof |
03/24/1992 | CA1297813C Process for production of insulin-like growth factor i |
03/24/1992 | CA1297789C Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor |
03/22/1992 | WO1992005444A1 Poly(fluoroalkyl) sugar reagents and their use for surface modification |
03/22/1992 | WO1992005266A2 Packaging cells |
03/22/1992 | WO1992004912A1 Composition for inducing granulocyte production or b cell production in peripheral blood |
03/22/1992 | CA2091177A1 Poly(fluoroalkyl) sugar reagents and their use for surface modification |
03/22/1992 | CA2051975A1 Polypeptide |
03/22/1992 | CA2051974A1 Polypeptide |
03/22/1992 | CA2051829A1 Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis |
03/22/1992 | CA2051796A1 Vascular endothelial cell growth factor ii |
03/21/1992 | CA2051721A1 Nasal pharmaceutical composition |
03/20/1992 | WO1992004911A1 Substantially pure interleukin-9 receptor and uses thereof |
03/19/1992 | WO1992005273A1 Gene therapy for cystic fibrosis |
03/19/1992 | WO1992004632A1 Methods for the diagnosis and treatment of diabetes |
03/19/1992 | WO1992004472A1 Antigens associated with polymyositis and with dermatomyositis |
03/19/1992 | WO1992004461A1 Genetically engineered coccidiosis vaccine |
03/19/1992 | WO1992004460A1 Genetically engineered coccidiosis vaccine |
03/19/1992 | WO1992004454A1 Compounds and constructs for producing male sterile plants |
03/19/1992 | WO1992004452A1 Transcription initiation regulating nucleotide sequence |
03/19/1992 | WO1992004451A1 Promoter probe vectors, able to replicate in e.coli, b.subtilis, lactococci and lactobacillus as well as uses thereof |
03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
03/19/1992 | WO1992004445A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
03/19/1992 | WO1992004442A1 Glial antiproliferative proteins |
03/19/1992 | WO1992004380A1 Specific binding agents |
03/19/1992 | WO1992004379A1 A new growth factor isolated from porcine spleen |
03/19/1992 | WO1992004378A1 Recombinant agents affecting thrombosis |
03/19/1992 | WO1992004376A1 Novel chemotactic factor |
03/19/1992 | WO1992004375A1 Hrsv vaccine |
03/19/1992 | WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
03/19/1992 | WO1992004366A1 Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material |
03/19/1992 | WO1992004363A1 Production of insulin-like growth factor-1 in methylotrophic yeast cells |
03/19/1992 | WO1992004050A1 Recombinant herpes simplex viruses vaccines and methods |
03/19/1992 | WO1992004045A1 Novel cholecystokinin antagonists, their preparation and therapeutic use |
03/19/1992 | WO1992004042A1 Glucagon analogs with asp9 replacements or deletions |
03/19/1992 | WO1992004039A1 Regulation of cell proliferation and differentiation using peptides |
03/19/1992 | WO1992004038A1 Pro-drugs for cck antagonists |
03/19/1992 | WO1992004035A1 Anti-inflammatory factor, method of isolation, and use |
03/19/1992 | WO1992003918A1 Transgenic non-human animals capable of producing heterologous antibodies |
03/19/1992 | WO1992003917A1 Homologous recombination in mammalian cells |
03/19/1992 | WO1992002612A3 Tissue plasminogen activator variants with decreased clearance |
03/19/1992 | WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide |
03/19/1992 | EP0484508A4 Proteinaceous fat substitute. |
03/19/1992 | DE4029227A1 Arzneimittel enthaltend cd14 Medicines containing CD14 |
03/19/1992 | CA2090473A1 Homologous recombinatin in mammalian cells |
03/19/1992 | CA2090410A1 Antithrombosis agents |
03/19/1992 | CA2090010A1 Nucleotidic sequence regulating the initiation of transcription |
03/19/1992 | CA2088195A1 Cholecystokinin antagonists, their preparation and therapeutic use |
03/18/1992 | WO1992005272A1 Method and composition for controlling proliferation of cells |
03/18/1992 | WO1992005264A1 Multiple promoter baculovirus expression system and defective particle production |
03/18/1992 | WO1992005191A1 Fungicidally active compounds |
03/18/1992 | EP0475927A2 Method of somatotropin naturation |
03/18/1992 | EP0475779A1 Process for the separation of proteins, polypeptides or metals using immobilized, optionally modified, phosvitin |
03/18/1992 | EP0475746A1 Human and murine interleukin-5 receptor |
03/18/1992 | EP0475719A2 Platelet derived growth regulating peptide |
03/18/1992 | EP0475656A2 The use of Bacillus thuringiensis microbes for controlling the lesser mealworm Alphitobius diaperinus |
03/18/1992 | EP0475623A1 Genetic mechanisms of tumor supression |
03/18/1992 | EP0475584A2 Inactivation of gene transcription in plants using altered transcriptional activators |
03/18/1992 | EP0475553A2 Life span determining protein and method of isolating the same |
03/18/1992 | EP0475478A1 Haemophilus paragallinarum vaccine |
03/18/1992 | EP0475394A2 Rat C-type natriuretic peptide cDNA and precursor protein |
03/18/1992 | EP0475354A2 Sialysation of glycoproteins by genetic technology |
03/18/1992 | EP0475311A1 Process for removing proteins originating from Escherichia coli |
03/18/1992 | EP0475292A2 Human luteinizing hormone-human chorionic gonadotropin receptor (Human LH/hCG receptor) |
03/18/1992 | EP0475291A1 A novel biologically active peptide derived from chicken (chicken CNP) |
03/18/1992 | EP0475290A1 A novel biologically active peptide derived from frog (frog CNP) |
03/18/1992 | EP0475230A1 Methods of conjugating actinomycin D |
03/18/1992 | EP0475185A1 DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same |
03/18/1992 | EP0475182A2 Method for protein synthesis using CKS fusion proteins |
03/18/1992 | EP0474979A1 Heparin binding neurotrophic factor gene sequence |
03/18/1992 | EP0474891A1 Vectors for expression of malarial antigens on the surface of Salmonella vaccine strains |
03/18/1992 | EP0474868A1 Method of producing core structure of retro virus and particle produced thereby |